Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 293 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

 
Table of Contents
LETTER TO THE EDITOR
Year : 2015  |  Volume : 19  |  Issue : 2  |  Page : 306-307

The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia


1 Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy
2 Department of Pediatrics, Division of Endocrinology, Hamad General Hospital, Doha, Qatar
3 Department of Medical Physics, St. Anna Hospital, Ferrara, Italy
4 Department of Pediatrics, Ain Shams University, Cairo, Egypt

Date of Web Publication14-Jan-2015

Correspondence Address:
Vincenzo De Sanctis
Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, 44100 Ferrara
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-8210.149331

Rights and Permissions

How to cite this article:
De Sanctis V, Soliman AT, Candini G, Elsedfy H. The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia. Indian J Endocr Metab 2015;19:306-7

How to cite this URL:
De Sanctis V, Soliman AT, Candini G, Elsedfy H. The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia. Indian J Endocr Metab [serial online] 2015 [cited 2017 Jun 28];19:306-7. Available from: http://www.ijem.in/text.asp?2015/19/2/306/149331

Dear Sir,

In a previous paper published in your journal, we reported the Position Statement and Guidelines on Growth and Endocrine Disorders in Thalassemia. [1] The diagnosis of growth hormone deficiency (GHD) is generally straightforward in children as growth retardation is present. However, in adults the diagnosis of GHD is often challenging. GHD in adults is a clinical syndrome associated with lack of positive well-being, depressed mood, feelings of social isolation, decreased energy, alterations in body composition with reduced bone and muscle mass, diminished exercise performance and cardiac capacity and altered lipid metabolism with increase in adiposity. [2]

In patients with chronic diseases, the clinical evaluation of GHD is difficult because signs and symptoms may be subtle and nonspecific, and universal provocative testing in all patients is difficult because the approach is cumbersome and expensive. [1],[2] Therefore, other markers are needed to identify adults who may have GHD and could potentially benefit from GH replacement therapy. Recent studies suggest that insulin-like growth factor-1 (IGF-1) may be used for primary screening, to avoid performing GH stimulation tests in the majority of healthy or diseased subjects, when appropriate normative sex and age-correlated ranges are available. [3] Therefore, the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine (ICET-A) promoted a study to collect more information on IGF-1 values in young adult Italian thalassemia major (TM) patients.

Plasma total IGF-1 was determined on ethylenediaminetetraacetic acid by chemiluminescent immunometric assay method (Nichols Institute Diagnostics, San Juan, CA). The assay was performed after separation of IGF-1 from binding proteins by Liaison; autoanalyzer (DiaSorin SpA, Saluggia, Italy). The sensitivity of the test was 6 ng/ml, whereas the intra- and inter-assay coefficients of variations of our in-house pooled serum control sample were 4.8% and 7.1%, respectively. Of the 120 patients, 58 (48%) were males and 62 (52%) females, with an age range of 26.0-53.2 years for females and 20.8-51.2 years for males. 64.4% of the patients were above 35 years of age. The mean body mass index was 22.48 ± 3.34 kg/m 2 .

The results, expressed in percentiles, are reported in [Figure 1]. No significant differences were observed between IGF-1 values in men and women with TM (Student's t-test: 1.18; P = 0.249).
Figure 1: Percentile of insulin-like growth factor-1 level in females and males with β thalassemia major

Click here to view


Based on the present results and data from the literature, ICET-A concluded their survey with the following recommendations: A GH stimulation test should be indicated in presence of the following clinical and laboratory parameters: Short stature (Height standard deviation scores <−2.5), severe and/or prolonged iron overload, presence of severe osteoporosis and/or serum IGF-I level <−2 standard deviations. Very low IGF-1 levels, especially in those patients with childhood-onset GHD, in the presence of pituitary iron deposition and/or atrophy are highly suggestive of GHD. [4] In adult TM patients, with normal liver function, an IGF-I level <50 th percentile [Figure 1] should be taken in consideration as a cut-off level for the GH assessment. [3]

With kindest regards and thanks from the ICET-A network.

 
   References Top

1.
De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, et al. Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian J Endocrinol Metab 2013;17:8-18.  Back to cited text no. 1
    
2.
Soliman A, De Sanctis V, Elsedfy H, Yassin M, Skordis N, Karimi M, et al. Growth hormone deficiency in adults with thalassemia: An overview and the I-CET recommendations. Georgian Med News 2013;79-88.  Back to cited text no. 2
    
3.
De Sanctis V, Soliman AT, Candini G, Yassin M, Raiola G, Galati MC, et al. Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major. Mediterr J Hematol Infect Dis 2014;6:e2014074.  Back to cited text no. 3
    
4.
Bogazzi F, Manetti L, Lombardi M, Giovannetti C, Raffaelli V, Urbani C, et al. Impact of different cut-off limits of peak GH after GHRH-arginine stimulatory test, single IGF1 measurement, or their combination in identifying adult patients with GH deficiency. Eur J Endocrinol 2011;164:685-93.  Back to cited text no. 4
    


    Figures

  [Figure 1]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

   Article Figures
  In this article
 References

 Article Access Statistics
    Viewed865    
    Printed7    
    Emailed0    
    PDF Downloaded293    
    Comments [Add]    

Recommend this journal